No insider purchase over the last 90 days. The latest, by ARMISTICE CAPITAL, LLC, was filed 18 Mar 2020.
AMAG Pharmaceuticals Inc. is a listed company. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for AMAG Pharmaceuticals Inc. The previous disclosure was published on 17 November 2020.
The full history, which starts in 2016, counts 33 purchases against 10 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
25 of 196 declarations
AMAG Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for women's health and chronic diseases. It is listed on NASDAQ under the symbol AMAG.